ReviewRSC advances2024
Green advancements towards the electrochemical synthesis of heterocycles.
Review in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Metal-Free Electrochemical Construction of Oxygen Heterocycles.Accounts of chemical research · 2026Article
- Investigation of the Semiconductor Properties and Chronoamperometry of BINanomaterials (Basel, Switzerland) · 2026Article
- Triazoles as enzyme inhibitors: synthetic advances, mechanism of action, molecular docking studies and structure-activity relationships.Molecular diversity · 2026Review
- Special Issue "Heterocyclic Compounds: Synthesis, Design, and Biological Activity".International journal of molecular sciences · 2026Article
- Visible-light promoted cascade annulation ofRSC advances · 2026Article
- Recent Applications of Albumin as a Green and Versatile Catalyst in Organic Synthesis.Molecules (Basel, Switzerland) · 2025Review
- Greener alternatives for synthesis of isoquinoline and its derivatives: a comparative review of eco-compatible synthetic routes.RSC advances · 2025Review
- Electrochemical cyclization of alkynes to construct five-membered nitrogen-heterocyclic rings.Beilstein journal of organic chemistry · 2025Review
- Heterocycles in Medicinal Chemistry II.Molecules (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heterocyclic chemistry is a large field with diverse applications in the areas of biological research and pharmaceutical advancement. Numerous initiatives have been proposed to further enhance the reaction conditions to reach these compounds without using harmful compounds. This paper focuses on the recent advances in the eco-friendly and green synthetic procedures to synthesize N-, S-, and O-heterocycles. This approach demonstrates considerable potential in accessing such compounds while circumventing the need for stoichiometric quantities of oxidizing/reducing agents or catalysts containing precious metals. Merely employing catalytic quantities of these substances proves sufficient, thereby offering an optimal means of contributing to resource efficiency. Renewable electricity plays a crucial role in generating environmentally friendly electrons (oxidant/reductant) that serve as catalysts for a series of reactions. These reactions involve the production of reactive intermediates, which in turn allow the synthesis of new chemical bonds, enabling beneficial transformations to occur. Furthermore, the utilization of metals as active catalysts in electrochemical activation has been recognized as an effective approach for achieving selective functionalization. The aim of this review was to summarize the electrochemical synthetic procedures so that the undesirable side reactions can be considerably reduced and the practical potential range of the chemical reactions can be expanded significantly.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.